Clinical Trial Update: Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Turoctocog Alfa for prophylaxis and treatment of bleeding episodes in previously treated Chinese patients with Haemophilia A has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Turoctocog alfa (turoctocog alfa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2019-08-26